SNAI3抗体—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P08787(SNAI3 Antibody) at dilution 1/25. (Original magnification: ×200)    

  
  

The SNAI3 antibody is a research tool designed to detect and study the SNAI3 protein, a member of the SNAIL family of zinc-finger transcription factors. SNAI3 (also known as Slug2 or SMUC) shares structural homology with SNAI1 (Snail) and SNAI2 (Slug), which are well-known regulators of epithelial-mesenchymal transition (EMT), a process critical in embryonic development, wound healing, and cancer metastasis. While SNAI1 and SNAI2 have been extensively studied, SNAI3 remains less characterized. It is implicated in transcriptional repression of target genes, particularly those involved in cell adhesion, differentiation, and apoptosis.

SNAI3 antibodies are primarily used in biomedical research to investigate its expression patterns, subcellular localization, and functional roles in various contexts. Studies suggest SNAI3 may contribute to cancer progression by promoting EMT, enhancing cell migration, and conferring resistance to therapies. However, its role appears context-dependent, with tissue-specific or cancer-type variations. Researchers employ these antibodies in techniques like Western blotting, immunohistochemistry, and immunofluorescence to explore SNAI3's involvement in tumorigenesis, stem cell biology, and developmental processes.

Due to potential cross-reactivity with other SNAIL family members, rigorous validation (e.g., knockout controls) is essential. Despite limited data, SNAI3 antibodies remain valuable for uncovering its unique biological functions and therapeutic potential in diseases like cancer.